Stock listing

TECH Stock Price, News, Filings & Events — Bio-techne Corp

Selected listing: TECH · NASDAQ · USD · US

This page tracks Bio-techne Corp's TECH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TECH:NASDAQ. TECH:NASDAQ is the stock-level entry point for investors researching Bio-techne Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bio-techne Corp, traded under the ticker TECH, is a public company based in the United States with a market capitalization of approximately $11.29 billion. The company specializes in providing high-quality biotech products and services. Bio-techne is committed to advancing scientific research and improving patient outcomes through innovative solutions in the life sciences sector.

TECH:NASDAQUSDUSUpdated August 31, 2026
Bio-techne Corp logo
Ticker
TECH:NASDAQ
Asset type
Stock
Market cap
$11.32B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Bio-techne Corp TECH:NASDAQ stock context

This page tracks Bio-techne Corp's TECH:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TECH:NASDAQ. TECH:NASDAQ is the stock-level entry point for investors researching Bio-techne Corp, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Bio-techne Corp, traded under the ticker TECH, is a public company based in the United States with a market capitalization of approximately $11.29 billion. The company specializes in providing high-quality biotech products and services. Bio-techne is committed to advancing scientific research and improving patient outcomes through innovative solutions in the life sciences sector.

Latest news from Bio-techne Corp

All Bio-techne Corp news →

Bio-techne Corp earnings calls

Research Bio-techne Corp

Alternate listings